We are live on ! Find out more
CFB

Cullen/Frost Bankers Portfolio holdings

AUM $10.1B
1-Year Est. Return 29.18%
This Fund
S&P 500
This Quarter Est. Return
+0.61%
1 Year Est. Return
+29.18%
3 Year Est. Return
+91.06%
5 Year Est. Return
+115.39%
10 Year Est. Return
+478.9%
AUM
$4.95B
AUM Growth
-$29.6M
Cap. Flow
-$37.3M
Cap. Flow %
-0.75%
Top 10 Hldgs %
26.9%
Holding
1,264
New
51
Increased
187
Reduced
349
Closed
44

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$16.3M
2
LRCX icon
Lam Research
LRCX
+$8.6M
3
TMO icon
Thermo Fisher Scientific
TMO
+$5.48M
4
PLD icon
Prologis
PLD
+$4.96M
5
KKR icon
KKR & Co
KKR
+$3.48M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$13.2M
2
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$9.37M
3
VZ icon
Verizon
VZ
+$8.94M
4
FCX icon
Freeport-McMoran
FCX
+$6.85M
5
AAPL icon
Apple
AAPL
+$5.53M

Sector Composition

Rank Sector Weight
1 Technology 22.28%
2 Financials 13.64%
3 Consumer Discretionary 10.89%
4 Healthcare 10.87%
5 Communication Services 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PBR icon
1151
Petrobras
PBR
$114B
$3K ﹤0.01%
300
– –
STE icon
1152
Steris
STE
$23.1B
$3K ﹤0.01%
14
-1,384
-99% -$296K
TEVA icon
1153
Teva Pharmaceuticals
TEVA
$42.8B
$3K ﹤0.01%
262
– –
U icon
1154
Unity
U
$19.6B
$3K ﹤0.01%
26
– –
CHUY
1155
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$3K ﹤0.01%
100
– –
AIEQ icon
1156
Amplify AI Powered Equity ETF
AIEQ
$124M
$2K ﹤0.01%
40
– –
AIV
1157
Aimco
AIV
$379M
$2K ﹤0.01%
297
– –
ALLT icon
1158
Allot
ALLT
$377M
$2K ﹤0.01%
125
– –
BE icon
1159
Bloom Energy
BE
$69.9B
$2K ﹤0.01%
110
– –
CRNT icon
1160
Ceragon Networks
CRNT
$201M
$2K ﹤0.01%
445
– –
EPP icon
1161
iShares MSCI Pacific ex Japan ETF
EPP
$2.26B
$2K ﹤0.01%
37
– –
GBDC icon
1162
Golub Capital BDC
GBDC
$3.4B
$2K ﹤0.01%
114
– –
HIMX
1163
Himax Technologies
HIMX
$2.63B
$2K ﹤0.01%
200
– –
NGVC icon
1164
Vitamin Cottage Natural Grocers
NGVC
$632M
$2K ﹤0.01%
200
– –
NUS icon
1165
Nu Skin
NUS
$236M
$2K ﹤0.01%
40
– –
PJT icon
1166
PJT Partners
PJT
$4.36B
$2K ﹤0.01%
20
– –
RDFN
1167
DELISTED
Redfin
RDFN
$2K ﹤0.01%
36
– –
TAK icon
1168
Takeda Pharmaceutical
TAK
$55.6B
$2K ﹤0.01%
125
– –
PDCO
1169
DELISTED
Patterson Companies, Inc.
PDCO
$2K ﹤0.01%
66
– –
NTG
1170
DELISTED
Tortoise Midstream Energy Fund, Inc. Common Stock
NTG
$2K ﹤0.01%
70
– –
APOG icon
1171
Apogee Enterprises
APOG
$897M
$1K ﹤0.01%
25
– –
BLDP
1172
Ballard Power Systems
BLDP
$790M
$1K ﹤0.01%
100
– –
CIX icon
1173
Comp X International
CIX
$386M
$1K ﹤0.01%
51
– –
CRSP icon
1174
CRISPR Therapeutics
CRSP
$5.22B
$1K ﹤0.01%
10
– –
ERIC icon
1175
Ericsson
ERIC
$33.4B
$1K ﹤0.01%
110
– –
45 46
47
48 49

Similar funds

RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
URS
Utah Retirement Systems Salt Lake City, Utah $9.78B AUM 28.72% 1-Year Est. Return

Cullen/Frost Bankers's Q3 2021 Portfolio in Review

As of Q3 2021, Cullen/Frost Bankers held 1,264 positions worth $4.95B, down 0.59% from $4.98B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Cullen/Frost Bankers's Q3 2021 filing shows 51 new, 187 increased, 349 reduced and 44 closed positions. Its largest new stake was KKR & Co: 55,414 shares worth $3.37M. The largest sale was Vertex Pharmaceuticals, an estimated $13.2M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cullen/Frost Bankers's largest Q3 2021 buy was KKR & Co: 55,414 shares worth $3.37M.
  • Cullen/Frost Bankers added most to Chevron in Q3 2021, an estimated $16.3M increase.
  • Cullen/Frost Bankers's biggest Q3 2021 reduction was Vertex Pharmaceuticals, cutting an estimated $13.2M.
  • Cullen/Frost Bankers fully exited Maxim Integrated Products in Q3 2021, selling an estimated $1.24M.
  • Cullen/Frost Bankers's ten largest holdings make up 27% of its $4.95B portfolio in Q3 2021.
  • Cullen/Frost Bankers opened 51 new positions and closed 44 in Q3 2021.
  • Cullen/Frost Bankers's portfolio value fell 0.59% quarter-over-quarter to $4.95B.

Based on Cullen/Frost Bankers's 13F filing for Q3 2021, filed 4 Nov 2021.